Phase I, Randomized, Double-blinded, Placebo-Controlled Dose De-escalation Study to Evaluate Safety and Immunogenicity of Alum Adjuvanted Zika Virus Purified Inactivated Vaccine (ZPIV) in Adults in a Flavivirus Endemic Area
Clinical trial NCT03008122 · COMPLETED
Trial details
- NCT number
- NCT03008122
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-21
- Primary completion
- 2021-08-10
- Enrollment
- 91
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.